Daniel Nettersheim

3.0k total citations
71 papers, 1.9k citations indexed

About

Daniel Nettersheim is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Nettersheim has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Surgery, 44 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Nettersheim's work include Testicular diseases and treatments (47 papers), Epigenetics and DNA Methylation (19 papers) and Sarcoma Diagnosis and Treatment (14 papers). Daniel Nettersheim is often cited by papers focused on Testicular diseases and treatments (47 papers), Epigenetics and DNA Methylation (19 papers) and Sarcoma Diagnosis and Treatment (14 papers). Daniel Nettersheim collaborates with scholars based in Germany, United States and Netherlands. Daniel Nettersheim's co-authors include Hubert Schorle, Sina Jostes, Katharina Biermann, Leendert H. J. Looijenga, Ad Gillis, Glen Kristiansen, Simon Schneider, Margaretha A. Skowron, Valerié Schumacher and Dawid Eckert and has published in prestigious journals such as PLoS ONE, Development and Scientific Reports.

In The Last Decade

Daniel Nettersheim

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Nettersheim Germany	27	1.4k	772	317	261	228	71	1.9k
Natini Jinawath Thailand	21	834 0.6×	202 0.3×	189 0.6×	175 0.7×	171 0.8×	59	1.5k
Hua Chang United States	15	1.4k 1.0×	163 0.2×	114 0.4×	255 1.0×	113 0.5×	34	1.8k
Michael G. Gartside Australia	21	1.2k 0.9×	221 0.3×	128 0.4×	117 0.4×	141 0.6×	38	1.8k
Luciano G. Martelotto United States	25	776 0.6×	223 0.3×	96 0.3×	176 0.7×	196 0.9×	62	1.7k
Jessamyn Bagley United States	20	650 0.5×	273 0.4×	184 0.6×	344 1.3×	64 0.3×	37	1.5k
Simone M. Rowley Australia	20	669 0.5×	85 0.1×	345 1.1×	523 2.0×	131 0.6×	38	1.4k
Irmgard Verdorfer Austria	17	370 0.3×	292 0.4×	51 0.2×	136 0.5×	188 0.8×	46	849
Masahiro Muto Japan	18	1.4k 1.0×	90 0.1×	51 0.2×	405 1.6×	132 0.6×	54	1.9k
Pierre Fouchet France	21	878 0.6×	95 0.1×	254 0.8×	336 1.3×	43 0.2×	46	1.5k
Caryn Y. Ito Canada	18	2.1k 1.6×	175 0.2×	32 0.1×	368 1.4×	444 1.9×	27	2.8k

Countries citing papers authored by Daniel Nettersheim

Since Specialization

Citations

This map shows the geographic impact of Daniel Nettersheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Nettersheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Nettersheim more than expected).

Fields of papers citing papers by Daniel Nettersheim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Nettersheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Nettersheim. The network helps show where Daniel Nettersheim may publish in the future.

Co-authorship network of co-authors of Daniel Nettersheim

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Nettersheim. A scholar is included among the top collaborators of Daniel Nettersheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Nettersheim. Daniel Nettersheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Skowron, Margaretha A., Felix Bremmer, Peter J. Kretschmer, et al.. (2025). Induction of SOX17 with stimulation of WNT, TGF‐beta, and FGF signaling drives embryonal carcinomas into the yolk‐sac tumor lineage resulting in increased cisplatin resistance. International Journal of Cancer. 156(11). 2210–2224. 1 indexed citations

Bremmer, Felix, Gereon Poschmann, Catena Kresbach, et al.. (2024). Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers. Cancer Letters. 585. 216673–216673. 2 indexed citations

Skowron, Margaretha A., Gereon Poschmann, Patrick Petzsch, et al.. (2024). Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages. Matrix Biology. 132. 10–23. 3 indexed citations

Nettersheim, Daniel, et al.. (2024). Pathogenesis and pathobiology of testicular germ cell tumours: a view from a developmental biological perspective with guidelines for pathological diagnostics. Histopathology. 85(5). 701–715. 4 indexed citations

Flores‐Romero, Hector, Margaretha A. Skowron, Christoph Peter, et al.. (2024). Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2. Cell Death Discovery. 10(1). 125–125. 5 indexed citations

Engler, Tobias, et al.. (2024). The New Tumour Biomarker miRNA‐371‐3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell Lines. Journal of Cellular and Molecular Medicine. 28(24). e70314–e70314.

Müller, Melanie, Margaretha A. Skowron, Patrick Petzsch, et al.. (2024). Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies. Experimental Cell Research. 439(1). 114055–114055. 1 indexed citations

Bremmer, Felix, Margaretha A. Skowron, Annika Richter, et al.. (2023). Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets. British Journal of Cancer. 129(10). 1580–1589. 16 indexed citations

Skowron, Margaretha A., Felix Bremmer, Annika Richter, et al.. (2023). Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular Medicine. 29(1). 8 indexed citations

10.

Skowron, Margaretha A., Katharina Raba, Patrick Petzsch, et al.. (2022). Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level. Molecular Oncology. 16(17). 3107–3127. 9 indexed citations

11.

Skowron, Margaretha A., Christoph Oing, Felix Bremmer, et al.. (2021). The developmental origin of cancers defines basic principles of cisplatin resistance. Cancer Letters. 519. 199–210. 29 indexed citations

12.

Skowron, Margaretha A., Sina Jostes, Felix Bremmer, et al.. (2021). The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. Molecular Oncology. 16(4). 982–1008. 14 indexed citations

13.

Schönberger, Stefan, Daniel Nettersheim, Hubert Schorle, et al.. (2020). Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines. Cancers. 12(5). 1279–1279. 5 indexed citations

14.

Lobo, João, Daniela Barros‐Silva, Vera Miranda‐Gonçalves, et al.. (2020). Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors. Cancers. 12(10). 2903–2903. 26 indexed citations

15.

Welter, H., Thomas Fröhlich, Florian Flenkenthaler, et al.. (2020). Filamin A Orchestrates Cytoskeletal Structure, Cell Migration and Stem Cell Characteristics in Human Seminoma TCam-2 Cells. Cells. 9(12). 2563–2563. 12 indexed citations

16.

Richter, Annika, Nadine T. Gaisa, Stefan Schweyer, et al.. (2020). The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain reaction. Histopathology. 78(4). 593–606. 39 indexed citations

17.

Nettersheim, Daniel, et al.. (2019). N6‐Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers. Andrology. 7(4). 498–506. 38 indexed citations

18.

Oing, Christoph, Margaretha A. Skowron, Carsten Bokemeyer, & Daniel Nettersheim. (2019). Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors: past, present, and future considerations. Andrology. 7(4). 487–497. 25 indexed citations

19.

Nettersheim, Daniel, Daniel R. Berger, Sina Jostes, Margaretha A. Skowron, & Hubert Schorle. (2018). Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors. Journal of Cellular and Molecular Medicine. 23(1). 670–679. 17 indexed citations

20.

Schönberger, Stefan, Daniel Nettersheim, Hubert Schorle, et al.. (2017). Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines. Journal of Cellular and Molecular Medicine. 22(1). 568–575. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact